- Description
- Specifications
Catalog #: IHA-031
Description:
Recombinant Full-Length H1N1 A/Solomon Islands/03/2006 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells.
Source:
Baculovirus Insect Cells.
Purity:
Greater than 90.0% as determined by SDS-PAGE.
Formulation:
The Recombinant H1N1 A/Solomon Islands/03/2006 solution contains 10mM Sodium phosphate, pH 7.1,150mM NaCl and 0.005% Tween-20.
Stability:
H1N1 A/Solomon Islands/03/2006 Recombinant should be stored at 4 °C.
Activity:
Western-Blot 0.1 µg -1 µg per strip, ELISA 1 µg/Well.
Physical Appearance:
Sterile Filtered colorless solution.
Usage:
Denovo Biotechnology's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
References:
1.Title: Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
Publication: The Rockefeller University Press, doi: 10.1084/jem.20101352
© 2011 Wrammert et al.
Link:http://jem.rupress.org/content/early/2011/01/06/jem.20101352.full
2.Title:Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine.
Publication:The Journal of Clinical Investigation http://www.jci.org Volume 120 Number 5 May 2010.
Link:http://www.jci.org/articles/view/41902/files/pdf
